首页> 外文期刊>Journal of Medical Radiation Sciences >Intensity modulated radiotherapy and 3D conformal radiotherapy for whole breast irradiation: a comparative dosimetric study and introduction of a novel qualitative index for plan evaluation, the normal tissue index
【24h】

Intensity modulated radiotherapy and 3D conformal radiotherapy for whole breast irradiation: a comparative dosimetric study and introduction of a novel qualitative index for plan evaluation, the normal tissue index

机译:用于全乳照射的强度调制放射疗法和3D适形放射疗法:比较剂量学研究并引入用于计划评估的新型定性指标,即正常组织指标

获取原文
           

摘要

AbstractIntroductionWe report on a retrospective dosimetric study, comparing 3D conformal radiotherapy (3DCRT) and hybrid intensity modulated radiotherapy (hIMRT). We evaluated plans based on their planning target volume coverage, dose homogeneity, dose to organs at risk (OARs) and exposure of normal tissue to radiation. The Homogeneity Index (HI) was used to assess the dose homogeneity in the target region, and we describe a new index, the normal tissue index (NTI), to assess the dose in the normal tissue inside the tangent treatment portal.MethodsPlans were generated for 25 early-stage breast cancer patients, using a hIMRT technique. These were compared with the 3DCRT plans of the treatment previously received by the patients. Plan quality was evaluated using the HI, NTI and dose to OARs.ResultsThe hIMRT technique was significantly more homogenous than the 3DCRT technique, while maintaining target coverage. The hIMRT technique was also superior at minimising the amount of tissue receiving D105% and above (P  0.0001). The ipsilateral lung and contralateral breast maximum were significantly lower in the hIMRT plans (P  0.05 and P  0.005), but the 3DCRT technique achieved a lower mean heart dose in left-sided breast cancer patients (P  0.05).ConclusionHybrid intensity modulated radiotherapy plans achieved improved dose homogeneity compared to the 3DCRT plans and superior outcome with regard to dose to normal tissues. We propose that the addition of both HI and NTI in evaluating the quality of intensity modulated radiotherapy (IMRT) breast plans provides clinically relevant comparators which more accurately reflect the new paradigm of treatment goals and outcomes in the era of breast IMRT.
机译:摘要简介我们报告了一项回顾性剂量学研究,比较了3D保形放射疗法(3DCRT)和混合强度调制放射疗法(hIMRT)。我们根据计划目标体积覆盖率,剂量均一性,对处于危险状态的器官的剂量(OAR)以及正常组织暴露于放射线的情况评估了计划。均一性指数(HI)用于评估目标区域的剂量均一性,我们描述了一个新的指标正常组织指数(NTI)来评估切线治疗门内正常组织中的剂量。使用hIMRT技术治疗25例早期乳腺癌患者。将这些与患者先前接受的治疗的3DCRT计划进行了比较。使用HI,NTI和OAR剂量评估计划质量。结果在保持目标覆盖率的同时,hIMRT技术比3DCRT技术具有更高的同质性。 hIMRT技术在使接受D 105%及以上的组织的数量最小化方面也具有优势(P <0.0001)。在hIMRT计划中,同侧肺和对侧乳腺的最大值显着降低(P <0.05和P <0.005),但是3DCRT技术在左侧乳腺癌患者中获得了较低的平均心脏剂量(P <0.05)。与3DCRT计划相比,放射线治疗计划提高了剂量均一性,并且在正常组织剂量方面取得了更好的效果。我们建议,在评估调强放疗(IMRT)乳腺计划的质量时,同时使用HI和NTI可以提供与临床相关的比较器,这些比较器可以更准确地反映乳腺IMRT时代的治疗目标和结局的新范式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号